“Genetic scissors” CRISPR/Cas9 genome editing cutting-edge biocarrier technology for bone and cartilage repair
Source abstract
Abstract
CRISPR/Cas9 is a revolutionary genome editing technology with the tremendous advantages such as precisely targeting/shearing ability, low cost and convenient operation, becoming an efficient and indispensable tool in biological research. As a disruptive technique, CRISPR/Cas9 genome editing has a great potential to realize a future breakthrough in the clinical bone and cartilage repairing as well. This review highlights the research status of CRISPR/Cas9 system in bone and cartilage repair, illustrates its mechanism for promoting osteogenesis and chondrogenesis, and explores the development tendency of CRISPR/Cas9 in bone and cartilage repair to overcome the current limitations.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: CRISPR and Genetic Engineering · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Cells, soluble factors and matrix harmonically play the concert of allograft integration10.1007/s00167-018-5182-1 ↗
2. Biologically modified implantation as therapeutic bioabsorbable materials for bone defect repair10.1016/j.reth.2021.12.004 ↗
3. Genetic and physical analysis of double-strand break repair and recombination in Saccharomyces cerevisiae10.1093/genetics/122.3.519 ↗
4. Highly active zinc-finger nucleases by extended modular assembly10.1101/gr.143693.112 ↗
5. Breaking the code of DNA binding specificity of TAL-type III effectors10.1126/science.1178811 ↗
6. Identification of genes that are associated with DNA repeats in prokaryotes10.1046/j.1365-2958.2002.02839.x ↗
7. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity10.1126/science.1225829 ↗
8. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds10.1016/j.biomaterials.2007.12.004 ↗
9. Elastic polyurethane bearing pendant TGF-β1 affinity peptide for potential tissue engineering applications10.1016/j.msec.2017.10.006 ↗
10. bFGF influences human articular chondrocyte differentiation10.1080/14653240601182846 ↗
11. Influence of bFGF on in vitro expansion and chondrogenic construction of articular cartilage-derived progenitor cells10.21037/atm-21-5604 ↗
12. BMP-2 and ALP gene expression induced by a BMP-2 gene-fibronectin-apatite composite layer10.1088/1748-6041/6/4/045004 ↗
13. Prolonged release of bone morphogenetic protein-2 in vivo by gene transfection with DNA-functionalized calcium phosphate nanoparticle-loaded collagen scaffolds10.1016/j.msec.2018.06.047 ↗
14. Functions of osteocalcin in bone, pancreas, testis, and muscle10.3390/ijms21207513 ↗
15. CRISPR technologies for stem cell engineering and regenerative medicine10.1016/j.biotechadv.2019.107447 ↗
16. Clinical application of bone marrow mesenchymal stem/stromal cells to repair skeletal tissue10.3390/ijms21249759 ↗
17. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer10.1186/s12943-022-01518-8 ↗
18. CRISPR/Cas9 for genome editing: progress, implications and challenges10.1093/hmg/ddu125 ↗
19. Delivering CRISPR: a review of the challenges and approaches10.1080/10717544.2018.1474964 ↗
20. Advances in therapeutic CRISPR/Cas9 genome editing10.1016/j.trsl.2015.09.008 ↗
21. Genome editing. The new frontier of genome engineering with CRISPR-Cas910.1126/science.1258096 ↗
22. Using gene editing approaches to fine-tune the immune system10.3389/fimmu.2020.570672 ↗
23. Precise genomic deletions using paired prime editing10.1038/s41587-021-01025-z ↗
24. CRISPR/Cas9 gRNA activity depends on free energy changes and on the target PAM context10.1038/s41467-022-30515-0 ↗
25. In vivo genome editing using Staphylococcus aureus Cas910.1038/nature14299 ↗
26. Crystal structure of Staphylococcus aureus Cas910.1016/j.cell.2015.08.007 ↗
27. CRISPR-Cas9 structures and mechanisms10.1146/annurev-biophys-062215-010822 ↗
28. Unprecedented diversity of unique CRISPR-cas-related systems and Cas1 homologs in asgard archaea10.1089/crispr.2020.0012 ↗
29. Adaptive evolution of a melanized fungus reveals robust augmentation of radiation resistance by abrogating non-homologous end-joining10.1111/1462-2920.15285 ↗
30. DNA double-strand break repair-pathway choice in somatic mammalian cells10.1038/s41580-019-0152-0 ↗
31. A review on electroporation-based intracellular delivery10.3390/molecules23113044 ↗
32. New method for efficient siRNA delivery in retina explants: reverse magnetofection10.1021/acs.bioconjchem.1c00132 ↗
33. Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo10.1073/pnas.1809671115 ↗
34. Multiparameter evaluation of in vivo gene delivery using ultrasound-guided, microbubble-enhanced sonoporation10.1016/j.jconrel.2015.12.001 ↗
35. Microinjection and micromanipulation: a historical perspective10.1007/978-1-4939-8831-0_1 ↗
36. Enhancing electrotransfection efficiency through improvement in nuclear entry of plasmid DNA10.1016/j.omtn.2018.02.009 ↗
37. Physical non-viral gene delivery methods for tissue engineering10.1007/s10439-012-0678-1 ↗
38. Efficient transfection of endothelial cells by a double-pulse electroporation method10.1089/dna.2009.0915 ↗
39. Gene delivery strategies for cartilage tissue engineering10.1016/j.addr.2006.03.005 ↗
40. Genetic dissection of axon regeneration via in vivo electroporation of adult mouse sensory neurons10.1038/ncomms1568 ↗
41. Gene transfer to plants by electroporation: methods and applications10.1007/s11033-020-05343-4 ↗
42. Current progress in electrotransfection as a nonviral method for gene delivery10.1021/acs.molpharmaceut.8b00207 ↗
43. An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes10.1371/journal.pone.0196891 ↗
44. Simplified pipelines for genetic engineering of mammalian embryos by CRISPR-Cas9 electroporation10.1093/biolre/ioz075 ↗
45. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
46. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery10.3390/ijms16048070 ↗
47. The magnetofection method: using magnetic force to enhance gene delivery10.1515/BC.2003.082 ↗
48. Nonviral locally injected magnetic vectors for in vivo gene delivery: a review of studies on magnetofection10.3390/nano11051078 ↗
49. Nucleic acid delivery using magnetic nanoparticles: the Magnetofection technology10.4155/tde.11.12 ↗
50. Recent advances in magnetofection and its potential to deliver siRNAs in vitro
51. Improved delivery of CRISPR/Cas9 system using magnetic nanoparticles into porcine fibroblast10.1007/s12033-018-0145-9 ↗
52. Cas9 ribonucleoprotein delivery via microfluidic cell-deformation chip for human T-cell genome editing and immunotherapy
53. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation10.1126/sciadv.1500454 ↗
54. A vector-free microfluidic platform for intracellular delivery10.1073/pnas.1218705110 ↗
55. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects10.1073/pnas.1015771108 ↗
56. Ultrasound mediated cellular deflection results in cellular depolarization
57. Augmentation of targeted delivery with pulsed high intensity focused ultrasound10.1080/02656730802093661 ↗
58. Applications of ultrasound-mediated drug delivery and gene therapy10.3390/ijms222111491 ↗
59. Sum · Non-viral Gene Delivery · 2018 · 110 · 3
60. Ultrasound triggered image-guided drug delivery10.1016/j.ejrad.2009.01.051 ↗
61. Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy10.1016/j.biomaterials.2019.119736 ↗
62. Plasmid-loadable magnetic/ultrasound-responsive nanodroplets with a SPIO-NP dispersed perfluoropentane core and lipid shell for tumor-targeted intracellular plasmid delivery10.1039/D0BM00699H ↗
63. Introduction of purified genes into mammalian cells10.3109/10409238409108719 ↗
64. Microinjection and micromanipulation: a historical perspective
65. Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation10.1186/s13059-019-1776-2 ↗
66. Embryo microinjection and knockout mutant identification of CRISPR/Cas9 genome-edited helicoverpa armigera (hübner)
67. Effect of ARTEMIS (DCLRE1C) deficiency and microinjection timing on editing efficiency during somatic cell nuclear transfer and in vitro fertilization using the CRISPR/Cas9 system10.1016/j.theriogenology.2021.04.003 ↗
68. Biosafety features of lentiviral vectors10.1089/hum.2012.229 ↗
69. Lentiviral vector pseudotypes: precious tools to improve gene modification of hematopoietic cells for research and gene therapy10.3390/v12091016 ↗
70. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector10.1126/science.272.5259.263 ↗
71. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses10.1038/s41586-019-0898-8 ↗
72. A self-restricted CRISPR system to reduce off-target effects10.1038/mt.2016.172 ↗
73. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening10.1038/nprot.2017.016 ↗
74. Adenovirus vectors: excellent tools for vaccine development10.4110/in.2021.21.e6 ↗
75. Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine10.1016/j.gendis.2017.04.001 ↗
76. Viral vector platforms within the gene therapy landscape10.1038/s41392-021-00487-6 ↗
77. Generation of the adenovirus vector-mediated CRISPR/Cpf1 system and the application for primary human hepatocytes prepared from humanized mice with chimeric liver10.1248/bpb.b18-00222 ↗
78. Dendrimers in biomedical applications--reflections on the field10.1016/j.addr.2005.09.018 ↗
79. All-in-one dendrimer-based lipid nanoparticles enable precise HDR-mediated gene editing in vivo10.1002/adma.202006619 ↗
80. A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing10.1126/sciadv.aaw8922 ↗
81. Liposome and immune system interplay: challenges and potentials10.1016/j.jconrel.2019.05.030 ↗
82. CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy10.1126/sciadv.abc9450 ↗
83. In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy10.1126/sciadv.abj6901 ↗
84. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice10.1038/s41467-021-26714-w ↗
85. Gemini and bicephalous surfactants: a review on their synthesis, micelle formation, and uses10.3390/ijms23031798 ↗
86. Micelle-like nanoparticles as carriers for DNA and siRNA10.1021/mp5007213 ↗
87. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain10.1016/j.jconrel.2021.02.026 ↗
88. HPV oncogene manipulation using nonvirally delivered CRISPR/Cas9 or natronobacterium gregoryi argonaute10.1002/advs.201700540 ↗
89. High loading of hydrophobic and hydrophilic agents via small immunostimulatory carrier for enhanced tumor penetration and combinational therapy10.7150/thno.38287 ↗
90. Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface10.1016/j.biomaterials.2020.120030 ↗
91. Bone tissue engineering and repair by gene therapy10.2741/2724 ↗
92. Size matters: defining critical in bone defect size10.1097/BOT.0000000000000978 ↗
93. Gene therapy for bone healing: lessons learned and new approaches10.1016/j.trsl.2021.04.009 ↗
94. Osteoclasts and remodeling based bone formation10.2174/1574888X10666151019115724 ↗
95. ELMO1 signaling is a promoter of osteoclast function and bone loss10.1038/s41467-021-25239-6 ↗
96. Jones · J. Bone Joint Surg. · 2006 · 88 · 143110.2106/JBJS.E.00381 ↗
97. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice10.1172/JCI15543 ↗
98. CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing10.1016/j.biomaterials.2020.120094 ↗
99. BMP signaling in mesenchymal stem cell differentiation and bone formation10.4236/jbise.2013.68A1004 ↗
100. Effects of BMP-9 and BMP-2 on the PI3K/Akt pathway in mc3t3-E1 preosteoblasts10.1089/ten.tea.2016.0151 ↗